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A cDNA fragment containing the coding sequence for the mature enzyme of human lysosomal proteinase cathepsin B 
was inserted in the pET plasmid expression vectors, so that it was placed under the control of transcription and transla- 
tion signals from bacteriophage T,. Upon induction, cathepsin B antigen was detected by in situ immunoscreening of 
lysed E. coli and by Western blot analysis of bacterial lysates. To our knowledge this is the first report of abundant synthe- 
sis of cloned cathepsin B in any expression system. Subfragments of cathepsin B can also be generated by this technique 
and will be used to study cathepsin B structure and function. 
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1. INTRODUCTION 
Cellular proteinases have distinct specificities 
and occupy various subcellular localizations [ 11. 
Among these enzymes, the cysteine proteinases 
must serve important cellular functions because 
they are found from protozoans to mammals [2]. 
The lysosomal acid hydr&se calhepsin B is une 
member of the cyst&e proteeinases. Ttis in~o1~ed 
in intr~ce&&ar fl&e& begra&aGeri, %3& has a&3 
been implicated in several diseases uch as tumor 
metast&s 13}. 3% &i~e ti ir~te~~teh in the 
biochemistry and mo’recular biology of cathepsin 
B. Towards this goal we have characterized pCB-1, 
a plasmid cDNA clone for human cathepsin B, and 
also several hgtll clones from both plasmid and 
phage human liver cDNA libraries [4,5]. In- 
dependently, h clones from human hepatoma and 
kidney cDNA libraries have been characterized by 
Dr D .P. Steiner and associates _&C. 
Catkepsin B is normally purified from mam- 
malian tissues such as spleen and liver but is dif- 
ficult to obtain in sufficient quantity. In this 
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communication, we reported our success with the 
synthesis of human cathepsin B protein in a pro- 
karyotic expression system developed by Dr 
William Studier and associates [7]. Human cathep- 
sin B cDNA was placed under the control of 
transcription and translation signals of bacterio- 
phage T,, and expressed in E. coli after induction 
of the TT RNA pu~~zzXXZ?se pr&ous~y c>onec) into 
the host bact&ai strain. 
2. MATERIALS AND METHODS 
2. J. f3%9.r0 of~~~rfi%.w~ yfffam
A flow chart for the construction of cathepsin B expression 
vector is shown in fig.1. The XC8 clone was screened from a 
human liver hgtl 1 cDNA library using an insert from our par- 
tial cathepsin B clone pCB-1. The library was a generous gift 
from Dr Vincent Kidd, University of Alabama at Birmingham 
[8]. After subcloning at the EcoRl restriction site into 
Ml3mpl9 for DNA sequencing, we found the clone had the 
zm@tie -s~ylmn-t cm1 *he -n,rdzun YX!~&, +hA Y?X&L . _.. 
3’ -untransl&ted’regibn ihcltidihg poly(A) ta$ dut only a limiied 
prxmqrmL~‘ljJ. ‘~~ttm,~m-drrGa~~ndn’rrsJz~~ iwftiiliit 
using the Ml3-C8 no.5 clone and a 19-mer oligonucleotide (syn- 
thesized at the University of Alabama at Birmingham) by the in 
vitro mutagenesis method of Nakamaye and Eckstein [9] 
(reagents from Amersham). This created a new PvuII restric- 
tion site at the first codon of the mature enzyme. The resulting 
PvuII-EcoRI fragment, containing 5’-cathepsin B coding se- 
quence (for codons l-250), was ligated to the 3’-EcoRI-PvuII 
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Fig.]. Construction of plasmid vectors pMC-4 and pMC-6 containing human cathepsin B cDNA. 
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fragment, containing the remaining codon sequence and some 
3’-untranslated segment, and cloned into pBR322 (pBR-CB 
nol20). BumHI linkers (New England BioLab) were added and 
again recloned into pBR322 (pMC-1). Human cathepsin B 
cDNA containing BarnHI linkers were cloned into pET3 expres- 
sion vectors and these were transformed into appropriate E. co/i 
strains for gene expression analysis. These latter vectors and 
hosts were kindly provided by Dr William Studier, Brookhaven 
National Laboratory. Standard molecular cloning techniques 
were done according to Maniatis et al. [lo]. 
2.2. In situ immunoscreening 
E. coli strains BL21(DE3) and BL21(DE3)pLysS, trans- 
formed with the pET3 plasmids containing human cathepsin B 
cDNA, were screened for gene expression after IPTG 
(isopropyl-&D-thiogalactoside) induction. The screening 
method of Helfman and Hughes [ 1 l] was followed with these 
modifications: we used horseradish peroxidase-conjugated 
sheep anti-human cathepsin B (Serotec) and diaminobenzidine 
as coloring reagent. 
2.3. Western blot analysis 
Prestained molecular mass standards (Amersham) and total 
bacterial lysates were separated by SDS-polyacrylamide gel 
(10%) electrophoresis and the protein blotted onto 
nitrocellulose filter using a Hoefer apparatus. The dye Ponceau 
S was used for total protein staining [12]. For antibody staining, 
the filter was pretreated with borate saline-bovine serum 
albumin and with normal goat serum; and the peroxidase- 
conjugated anti-human cathepsin B (Serotec) was pre-treated 
with bacterial lysate (without cathepsin B plasmid) for 
background reduction. 
3. RESULTS 
3.1. Screening for human cathepsin B expression 
in E. coli 
Human cathepsin B cDNA containing BamHI 
linkers was cloned into the BamHI site of pET3 ex- 
pression vectors. The ligated plasmids were first 
used to transform E. coli HMS174, and those con- 
taining cathepsin B inserts were then used to 
transform other host strains for immunoscreening. 
After IPTG induction, bacterial clones producing 
immunoreactive cathepsin were detected as dark 
brown spots on nitrocellulose filters (not shown). 
By restriction mapping of plasmid DNA, we 
isolated pMC-4, a clone with the correct orienta- 
tion for transcription, and pMC-6, one with the 
opposite orientation (fig. 1). 
3.2. Characterization of human cathepsin B 
produced in bacteria 
Bacterial gene products were analyzed by pro- 
tein blotting. Upon IPTG induction, one promi- 
nent protein band at approximately 33 kDa was 
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Fig.2. Western blot of bacterial Iysates to anti-human cathepsin 
B. Lanes: (1) molecular mass standards; (2) pMC-4 lysate, 
protein stain; (3) pMC-6 lysate, protein stain; (4) pMC-4 lysate, 
antibody binding; (5) pMC-6 lysate, antibody binding. 
observed (fig.2, lane 2). The band was absent in 
lysate containing the opposite-orientation plasmid 
(fig.2, lane 3); and the band was immunoreactive 
to human cathepsin B antiserum (fig.2, lane 4). 
Thus a 33 kDa cathepsin B antigen was generated 
by the PET expression vector system. We have also 
found that the expression was stable in the host 
BL21(DE3)pLysS but not in BL21(DE3). The 
former bacterial host has an additional plasmid 
coding for the T7 lysozyme gene that improves on 
the T7 gene expression system [ 131. 
4. DISCUSSION 
Maximizing gene expression in bacteria involves 
a variety of conditions [14]. For the expression of 
cloned human cathepsin B cDNA, we were unsuc- 
cessful in our initial attempts with plasmid vectors 
including pUC-18 and pKK233-2 ([15], not 
shown), but we achieved cathepsin B synthesis with 
the pET3 vectors that contain the strong 
bacteriophage T7 410 promoter. To our 
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knowledge, this is the first demonstration of abun- 
dant protein synthesis from cloned cathepsin B 
cDNA in any gene expression system. 
The 33 kDa cathepsin B protein can thus be ex- 
pressed in sufficient quantity for our next goal: to 
study cathepsin B structure and function. Overlap- 
ping cathepsin B peptide fragments can be pro- 
duced by the same technique, with the construction 
of a series of deletion mutants from the pMC-4 
plasmid containing the cathepsin B cDNA. 
Bacterially expressed protein and peptide frag- 
ments will be readily available sources of materials 
for generating monoclonal and polyclonal anti- 
bodies, which will be used to assess the relevance 
of different regions of cathepsin B for the expres- 
sion of its biological activities. That this approach 
is feasible with the T7 expression system has been 
demonstrated for human factor IX [ 161. 
Studier for their help, Misses Mei-feng Cui and Kathleen 
Shelton for technical assistance, and MS Lynn Weingart for 
manuscript preparation. M.M.C. is a Busch Postdoctoral 
Fellow. This work was supported by National Science Founda- 
tion Grant DCB 88-96114 to D.F. 
REFERENCES 
[l] Bond, J.S. and Butler, P.E. (1987) Annu. Rev. Biochem. 
56, 333-364. 
[2] Turk, V. (1986) Cysteine Proteinases and Their 
Inhibitors, Walter de Gruyter, Berlin. 
[3] Sloane, B.F., Rozhin, J., Hatfield, J.S., Crissman, J.D. 
141 
and Honn, K.V. (1987) Exp. Cell Biol. 55, 209-224. 
Fong, D., Calhoun, D.H., Hsieh, W.T., Lee, B. and 
Wells, R.D. (1986) Proc. Natl. Acad. Sci. USA 83, 
2909-29 13. 
151 
161 
Normal human cathepsin B has 252 amino acids 
[ 171. Our bacterially expressed 33 kDa product ac- 
tually is a fusion protein. It contains the first 11 
amino acids of the T7 gene 10 protein, the inframe 
BamHI linker, the 254 amino acids (252 amino 
acids plus a 2 amino acid linkage between light and 
heavy chain) and a 6 amino acid carboxyl-terminal 
extension peptide of cathepsin B. Enzyme activity 
has not been detected. Unlike normal cathepsin B, 
the bacterially expressed product is not 
glycosylated. In the normal 252 amino acid cathep- 
sin B there is a further cleavage into a light chain 
and a heavy chain [17]. Processing of cathepsin B 
by the aspartic proteinases pepsin and cathepsin D 
has been documented [l&20]. Our bacterially 
derived cathepsin B may thus also be used as 
substrate for the study of cathepsin B processing 
enzymes. 
[71 
181 
Fong, D. (1987) Fed. Proc. 46, 491. 
Chan, S.J., San Segundo, B., McCormick, M.B. and 
Steiner, D.F. (1986) Proc. Nat]. Acad. Sci. USA 83, 
7721-1725. 
Rosenberg, A.H., Lade, B.N., Chui, D.S., Lin, S.W., 
Dunn, J.J. and Studier, F.W. (1987) Gene 56, 125-135. 
Humphreys-Beher, M.G., Bunnell, B., VanTuinen, P., 
Ledbetter, D.H. and Kidd, V.J. (1986) Proc. Natl. Acad. 
Sci. USA 83, 8918-8922. 
[91 
t101 
1111 
[=I 
[I31 
[I41 
Nakamaye, K.L. and Eckstein, F. (1986) Nucleic Acids 
Res. 14, 9679-9698. 
Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) 
Molecular Cloning: A Laboratory Manual, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY. 
Helfman, D.A. and Hughes, S.H. (1987) Methods 
Enzymol. 152, 451-457. 
Salinovich, 0. and Montelaro, R.C. (1986) Anal. 
Biochem. 156, 341-347. 
Moffatt, B.A. and Studier, F.W. (1987) Cell 49,221-227. 
Reznikoff, W.S. and Gold, L. (1986) Maximizing Gene 
Expression, Butterworths, Stoneham, MA. 
[15] Amann, E. and Brosius, J. (1985) Gene 40, 183-190. 
[16] Lin, S.W., Dunn, J.J., Studier, F.W. and Stafford, D.W. 
(1987) Biochemistry 26, 5267-5274. 
[17] Ritonja, A., Popovic, T., Turk, V., Wiedenmann, K. and 
Machleidt, W. (1985) FEBS Lett. 181, 169-172. 
[18] Mort, J.S. and Recklies, A.D. (1986) Biochem. J. 233, 
57-63. 
Acknowledgements: We thank Dr Bonnie Sloane for a poster 
presentation of these data at the 7th International Symposium 
[19] Nishimura, Y. and Kato, K. (1987) Biochem. Biophys. 
Res. Commun. 148, 254-259. 
on Intracellular Protein Catabolism in Japan, May 1988. We 
are grateful to Drs John Bird, Vincent Kidd and William 
[20] Nishimura, Y., Kawabata, T. and Kato, K. (1988) Arch. 
Biochem. Biophys. 261, 64-71. 
222 
